{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:58:16Z","timestamp":1748667496527},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.beha.2014.11.003","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T03:07:00Z","timestamp":1415675220000},"page":"14-21","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunophenotyping for diagnosis and prognosis in MDS: Ready for general application?"],"prefix":"10.1016","volume":"28","author":[{"given":"Eline M.P.","family":"Cremers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Alhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresia M.","family":"Westers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert J.","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan A.","family":"van de Loosdrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2014.11.003_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2014.11.003_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2014.11.003_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.beha.2014.11.003_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.beha.2014.11.003_bib5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.leukres.2007.03.015","article-title":"Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface","volume":"31","author":"Wimazal","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2014.11.003_bib6","first-page":"1","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","author":"Malcovati","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib7","first-page":"1","article-title":"Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment","author":"Burbury","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2014.11.003_bib8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"Van de Loosdrecht","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2014.11.003_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.leukres.2011.09.015","article-title":"Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch working party on flow cytometry in MDS","volume":"36","author":"Westers","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2014.11.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20008","article-title":"Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts","volume":"60","author":"Van Lochem","year":"2004","journal-title":"Cytom Part B Clin Cytom"},{"key":"10.1016\/j.beha.2014.11.003_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2014.11.003_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.6004\/jnccn.2013.0106","article-title":"Cutting edge: flow cytometry in myelodysplastic syndromes","volume":"11","author":"Van de Loosdrecht","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.beha.2014.11.003_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1445-5994.2011.02630.x","article-title":"Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes","volume":"42","author":"Xu","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.beha.2014.11.003_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3324\/haematol.2011.057158","article-title":"Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes","volume":"97","author":"Sandes","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2014.11.003_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.leukres.2011.02.016","article-title":"Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes","volume":"35","author":"Chu","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2014.11.003_bib17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2014.11.003_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2141.2010.08146.x","article-title":"Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes","volume":"149","author":"Xu","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2014.11.003_bib19","doi-asserted-by":"crossref","first-page":"e88706","DOI":"10.1371\/journal.pone.0088706","article-title":"Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes","volume":"9","author":"Xu","year":"2014","journal-title":"PLoSone"},{"key":"10.1016\/j.beha.2014.11.003_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ijlh.12151","article-title":"Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation","volume":"36","author":"Wangen","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.beha.2014.11.003_bib21","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3109\/10428194.2013.781167","article-title":"Immunophenotypic profile of nucleated erythroid progenitors during maturation in regenerating bone marrow","volume":"54","author":"Fajtova","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2014.11.003_bib22","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2014.11.003_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.leukres.2012.08.008","article-title":"The classification of MDS: from FAB to WHO and beyond","volume":"36","author":"Vardiman","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2014.11.003_bib24","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib25","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib26","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.beha.2014.11.003_bib27","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.beha.2014.11.003_bib28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"Van de Loosdrecht","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib29","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2008-05-153700","article-title":"Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome","volume":"112","author":"Scott","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.12994","article-title":"High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes","volume":"167","author":"Alhan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2014.11.003_bib31","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2014.11.003_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.b.20513","article-title":"Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients","volume":"78","author":"Matarraz","year":"2010","journal-title":"Cytom Part B, Clin Cytom"},{"key":"10.1016\/j.beha.2014.11.003_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/10428194.2012.718341","article-title":"Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an international consortium and the European LeukemiaNet working group","volume":"54","author":"Van de Loosdrecht","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2014.11.003_bib34","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-08-239749","article-title":"Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment","volume":"115","author":"Westers","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2014.11.003_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cyto.b.21160","article-title":"Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes","volume":"86","author":"Alhan","year":"2014","journal-title":"Cytom Part B Clin Cytom"},{"key":"10.1016\/j.beha.2014.11.003_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2012.066787","article-title":"Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics","volume":"98","author":"Kern","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2014.11.003_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cyto.b.20582","article-title":"Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias","volume":"80","author":"Cutler","year":"2011","journal-title":"Cytom Part B Clin Cytom"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692614000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692614000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T22:21:10Z","timestamp":1717539670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692614000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1521692614000838"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2014.11.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunophenotyping for diagnosis and prognosis in MDS: Ready for general application?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2014.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}